Securities Code: 300813
Securities Abbreviation: Tailin Bioengineering
Announcement No.: 2026-058
Zhejiang Tailin Bioengineering Co., Ltd.
Announcement on Termination of Offering Convertible Bonds to Unspecified Objects and Withdrawal of Application Documents
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Zhejiang Tailin Bioengineering Co., Ltd. (hereinafter referred to as the "Company") held the 15th meeting of the Fourth Board of Directors on August 14, 2026, and reviewed and approved the "Proposal on Terminating the Offering of Convertible Bonds to Unspecified Objects and Withdrawing Application Documents." The Company agreed to terminate the current offering of convertible bonds to unspecified objects and apply to the Shenzhen Stock Exchange (hereinafter referred to as the "SZSE") to withdraw the relevant application documents.
The Company's 2025 Annual General Meeting of Shareholders authorized the Board of Directors to handle all matters related to the offering of convertible bonds. This proposal does not require submission to the Shareholders' Meeting for deliberation. The specific content is hereby announced as follows:
I. Basic Information on the Current Offering of Convertible Bonds to Unspecified Objects
The Company held the 11th meeting of the Fourth Board of Directors on March 25, 2026, and reviewed and approved the relevant proposals for the Company's offering of convertible bonds to unspecified objects. For the specific content, please refer to the relevant announcement disclosed by the Company on the Juchao Information Network (http://www.cninfo.com.cn) on March 27, 2026.